| Catalog Number |
Chemical Name |
Molecular Formula |
| AP10571 |
CAS 1334513-02-8 | N-[(S)-(2,3,4,5,6-Pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-methylethyl ester |
C18H17F5NO5P |
| AP10568 |
CAS 146464-90-6 | Benzeneacetic acid, 4-(methoxycarbonyl)-α-2-propyn-1-yl-, methyl ester |
C14H14O4 |
| AP10567 |
CAS 146464-93-9 | 4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoic acid |
C18H16N6O2 |
| AP10566 |
CAS 1548618-47-8 | 6-Pteridinepropanoic acid, 2,4-diamino-α-[4-(methoxycarbonyl)phenyl]-α-2-propyn-1-yl-, methyl ester, hydrobromide |
C21H21BrN6O4 |
| AP10564 |
CAS 146464-92-8 | 6-Pteridinepropanoic acid, 2,4-diamino-α-(4-carboxyphenyl)-α-2-propyn-1-yl- |
C19H16N6O4 |
| AP10563 |
CAS 1497287-42-9 | 6-Pteridinepropanoic acid, 2,4-diamino-α-(4-carboxyphenyl)-α-2-propyn-1-yl-, hydrochloride |
C19H17ClN6O4 |
| AP10562 |
CAS 146464-95-1 | Pralatrexate |
C23H23N7O5 |
| AP10561 |
CAS 118292-06-1 | 4,4-Dimethyl-6-ethynylthiochroman |
C13H14S |
| AP10559 |
CAS 118292-40-3 | Tazarotene |
C21H21NO2S |
| AP10553 |
CAS 187223-15-0 | (2S,4R)-4-[[[[2-[[(1,1-Dimethylethoxy)carbonyl]amino]ethyl]amino]carbonyl]oxy]-1,2-pyrrolidine dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester |
C28H33N3O8 |
| AP10549 |
CAS 191732-72-6 | Lenalidomide |
C13H13N3O3 |
| AP10544 |
CAS 1026200-27-0 | L-Valine, 3-Methyl-N-[[[(1R,2R)-2-(4-penten-1-yl)cyclopropyl]oxy]carbonyl]- |
C15H25NO4 |
| AP10543 |
CAS 1361028-94-5 | L-Proline, 4-[(3-chloro-7-methoxy-2-quinoxalinyl)oxy]-, methyl ester, (hydrochloride)(1:1),(4R)- |
C15H17Cl2N3O4 |
| AP10542 |
CAS 1206524-86-8 | Grazoprevir (potassium salt) |
C38H49KN6O9S |
| AP10539 |
CAS 1421372-66-8 | N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine |
C25H31N7O |
| AP10538 |
CAS 1421372-67-9 | N-(2-dimethylamino-ethyl)-2-methoxy-N-methyl-N-[4-(1-methyl-1h-indol-3-yl)-pyrimidin-2-yl]-5-nitro-benzene-1,4-diamine |
C25H29N7O3 |
| AP10537 |
CAS 187722-18-5 | 3-(methylthio)propyl 4-methylbenzenesulfonate |
C11H16O3S2 |
| AP10535 |
CAS 1000414-38-9 | (S)-methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate |
C11H12O4 |
| AP10533 |
CAS 1000413-72-8 | Fasiglifam |
C29H32O7S |
| AP10527 |
CAS 1147103-42-1 | Cyclopenta[c]pyrrole-1-carboxylic acid, octahydro-, ethyl ester, hydrochloride (1:1), (1S,3aR,6aS)- |
C10H18ClNO2 |
| AP10519 |
CAS 14328-51-9 | L-alpha-Cyclohexylglycine |
C8H15NO2 |
| AP10518 |
CAS 14328-63-3 | Cyclohexaneacetic acid, α-amino-, methyl ester, hydrochloride, (S)- |
C9H18ClNO2 |
| AP10512 |
CAS 183288-43-9 | 5-[4-(tert-butoxycarbonyl)-1-piperazinyl]benzofuran-2-carboxylic acid ethyl ester |
C20H26N2O5 |
| AP10511 |
CAS 15861-24-2 | 1H-indole-5-carbonitrile |
C9H6N2 |
| AP10509 |
CAS 10075-50-0 | 5-Bromoindole |
C8H6BrN |
| AP10508 |
CAS 163521-08-2 | Vilazodone (Hydrochloride) |
C26H28ClN5O2 |
| AP10507 |
CAS 1422956-31-7 | 2-Benzofurancarboxylic acid, 5-(1-piperazinyl)-, ethyl ester, (Hydrochloride), hydrate (1:2:1) |
C15H22Cl2N2O4 |
| AP10506 |
CAS 174775-48-5 | ethyl 5-aminobenzofuran-2-carboxylate |
C11H11NO3 |
| AP10505 |
CAS 163521-19-5 | 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxylic acid |
C26H26N4O3 |
| AP10504 |
CAS 183288-44-0 | tert-butyl4-(2-carbamoylbenzofuran-5-yl)piperazine-1-carboxylate |
C18H23N3O4 |
